A clearer view of evidence in treating macular degeneration: off-label policies and independent research

The Cochrane database of systematic reviews

Volumn 9, Issue , 2014, Pages ED000090-

  Formoso, Giulio ^a   Marata, Anna M aria ^a   Magrini, Nicola ^a   Bero, Lisa ^a  

^a Regional Agency for Health and Social Care   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENESIS INHIBITOR; BEVACIZUMAB; MONOCLONAL ANTIBODY; RANIBIZUMAB;

AGED; DRUG INDUSTRY; ECONOMICS; EUROPE; FEE; HUMAN; ITALY; LEGISLATION AND JURISPRUDENCE; LITERATURE; MACULAR DEGENERATION; OFF LABEL DRUG USE; RANDOMIZED CONTROLLED TRIAL (TOPIC); UNITED STATES;

AGED; ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL, HUMANIZED; DRUG INDUSTRY; EUROPE; FEES, PHARMACEUTICAL; HUMANS; ITALY; MACULAR DEGENERATION; OFF-LABEL USE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; REVIEW LITERATURE AS TOPIC; UNITED STATES;

EID: 84931064839     PISSN: None     EISSN: 1469493X     Source Type: Journal    
DOI: 10.1002/14651858.ED000090     Document Type: Editorial

References (0)